Over the last few years, a new category of mental health service has emerged: online ketamine therapy. Companies like Mindbloom, Joyous, and others now offer ketamine treatment that can be prescribed remotely and taken at home, without a clinic visit, without medical supervision during the session, and without the oversight of a psychiatrist who knows your full history.
For patients who have been struggling with depression and are looking for any path forward, the appeal is understandable. It is accessible, relatively affordable, and does not require you to leave your house.
But the convenience comes with trade-offs that are worth understanding clearly before you make a decision. This post lays out exactly how online and in-person ketamine differ, where each approach has merit, and why for most patients dealing with serious depression, clinic-based care at a practice like NeuPath Mind Wellness produces meaningfully better outcomes.
What Online Ketamine Actually Is
Online ketamine services operate through a telehealth model. A patient completes an intake form and a brief virtual consultation with a prescribing clinician, often a nurse practitioner rather than a psychiatrist, and if approved receives a prescription for oral or sublingual ketamine lozenges that are mailed to their home.
The patient then takes the ketamine at home, typically alone or with a friend or partner, without any clinical monitoring during the session. Some platforms provide a virtual companion or therapist to check in before and after, but the session itself is unsupervised.
The ketamine used in these models is almost always oral or sublingual, meaning it is swallowed or dissolved under the tongue. This form of administration has significantly lower bioavailability than intravenous ketamine, meaning a much smaller proportion of the drug actually reaches the brain. The dissociative experience is milder, the therapeutic effect is less predictable, and the dosing is less precise.
What In-Person Ketamine at NeuPath Looks Like
At NeuPath Mind Wellness, ketamine therapy is administered intravenously under direct medical supervision in a calm, private clinical environment.
IV ketamine delivers the drug directly into the bloodstream at a precisely controlled rate, producing consistent plasma concentrations and a predictable, clinically meaningful therapeutic effect. The session is monitored throughout by trained clinical staff who track your vital signs, adjust the infusion rate as needed, and are present for the entirety of the experience.
Your treatment at NeuPath is overseen by a psychiatrist who knows your full history, your diagnosis, your medication background, and your treatment goals. Dosing decisions are made by that psychiatrist based on your individual response, not by a remote prescriber who spent fifteen minutes reviewing your intake form.
Before your first infusion, you have a comprehensive psychiatric evaluation. After each session, your response is assessed and your treatment plan is adjusted accordingly. The ketamine does not exist in isolation from the rest of your care.
The Key Differences
Bioavailability and Therapeutic Effect
This is the most clinically significant difference between the two models.
IV ketamine has near-complete bioavailability. When delivered intravenously, essentially all of the drug reaches systemic circulation and crosses the blood-brain barrier at the intended concentration. The therapeutic effect is consistent, predictable, and well-documented across decades of clinical research.
Oral and sublingual ketamine have bioavailability of approximately 20 to 30 percent. The majority of the drug is broken down in the digestive tract and liver before it reaches the brain. What arrives at the target site is a fraction of the administered dose, at concentrations that are harder to predict and control.
This difference matters clinically. The robust antidepressant effects documented in ketamine research are based almost entirely on intravenous administration. Extrapolating those results to oral formulations requires assumptions that the evidence does not yet fully support.
Medical Supervision and Safety
Ketamine is a dissociative anesthetic. During an infusion, patients experience altered states of perception, changes in sense of time and space, and in some cases intense emotional or psychological experiences. These effects are transient and resolve after the session, but they require clinical oversight.
At NeuPath, a trained clinician is present throughout every infusion. Vital signs are monitored continuously. If a patient experiences cardiovascular changes, significant distress, or an unexpected reaction, the clinical team responds immediately.
Taking ketamine at home alone removes that safety net entirely. The risk is not theoretical. Ketamine affects blood pressure and heart rate, can cause nausea and vomiting in some patients, and produces psychological experiences that can be disorienting or distressing without appropriate support. Unsupervised use in a home environment introduces risks that supervised clinical administration does not.
Psychiatric Oversight
Perhaps the most underappreciated difference between online and in-person ketamine is the quality of the clinical relationship overseeing the treatment.
Online ketamine platforms are primarily prescription services. The clinical relationship is thin by design. A brief telehealth consultation, often with a non-psychiatrist prescriber, is not equivalent to a comprehensive psychiatric evaluation with a clinician who understands the full complexity of your depression, your comorbidities, your medication history, and your treatment goals.
At NeuPath, your ketamine treatment is embedded within a broader psychiatric care relationship. Your psychiatrist monitors your response over the course of treatment, identifies when a different approach might serve you better, and coordinates your ketamine care with any other treatments you are receiving, including TMS, Spravato, or GeneSight-informed medication management.
That coordination is not possible in a model where the prescriber met you once on a video call.
Integration With Other Treatments
For many patients, ketamine works best as part of a broader treatment strategy rather than as a standalone intervention. The neuroplastic window that ketamine opens, the period immediately following an infusion when the brain is particularly receptive to new learning and connection, is an opportunity that can be amplified by therapy, by TMS, or by other supportive interventions.
At NeuPath, we can combine ketamine with TMS therapy, Spravato, and psychiatric medication management in a coordinated plan. Online ketamine platforms offer none of this. The ketamine is the product, and the clinical relationship ends there.
Online ketamine services prescribe oral or sublingual ketamine lozenges taken at home without clinical supervision. In-person ketamine at NeuPath uses intravenous administration under direct medical oversight with a psychiatrist managing your full treatment plan. The bioavailability, therapeutic effect, safety profile, and quality of clinical oversight differ significantly between the two models.
No. IV ketamine has near-complete bioavailability, meaning essentially all of the drug reaches the brain at the intended concentration. Oral and sublingual ketamine have bioavailability of approximately 20 to 30 percent. The robust antidepressant effects documented in clinical research are based almost entirely on intravenous administration.
Unsupervised home ketamine carries risks that clinic-based administration does not. Ketamine affects blood pressure and heart rate, can cause nausea and vomiting, and produces dissociative experiences that can be disorienting without clinical support. At NeuPath, trained clinical staff monitor every infusion and respond immediately if needed.
Telehealth ketamine platforms do operate in Florida, but the clinical oversight they provide is significantly thinner than what a psychiatry practice like NeuPath offers. A brief virtual consultation with a remote prescriber is not equivalent to a comprehensive psychiatric evaluation with a clinician who manages your full treatment.
Where Online Ketamine Has a Role
This post is not an argument that online ketamine has no place in mental health treatment. For patients with mild to moderate depression who live in areas without access to a ketamine clinic, who cannot afford IV ketamine out of pocket, or who are using oral ketamine as a bridge while awaiting in-person treatment, it may provide meaningful benefit.
The oral formulations used by telehealth platforms are not inert. Some patients do experience real improvement from sublingual ketamine, and the accessibility advantage is genuine for patients in underserved areas.
But for patients with moderate to severe depression, treatment-resistant presentations, complex psychiatric histories, or significant comorbidities, the clinical limitations of unsupervised home ketamine are real and worth weighing carefully against the convenience.
For patients with moderate to severe depression, treatment-resistant presentations, or complex psychiatric histories, the clinical advantages of supervised IV ketamine, including higher bioavailability, medical monitoring, and psychiatric oversight, produce meaningfully better outcomes than unsupervised oral ketamine for most patients.
Yes. At NeuPath, ketamine therapy can be coordinated with TMS, Spravato, and GeneSight-informed medication management as part of an integrated treatment plan. This kind of coordination is not possible through an online ketamine platform where the clinical relationship ends with the prescription.
Book a free consultation at NeuPath Mind Wellness. Our psychiatrists will review your history, your diagnosis, and your treatment goals and give you an honest assessment of whether IV ketamine, TMS, Spravato, or a combination approach is the best fit for your situation.
The Question Worth Asking
When you are evaluating ketamine treatment options, the most important question is not which option is most convenient or most affordable. It is which option is most likely to produce a genuine, lasting improvement in your mental health.
For the large majority of patients dealing with serious depression, the answer to that question is supervised, intravenous, psychiatrist-overseen ketamine therapy in a clinical setting, with access to the full range of complementary treatments when they are needed.
That is what NeuPath Mind Wellness offers.
| Ketamine Therapy at NeuPath Mind Wellness |
|---|
| NeuPath Mind Wellness offers IV ketamine infusion therapy across all three of our South Florida locations in Delray Beach, Boca Raton, and Boynton Beach. Every infusion is administered by trained clinical staff, overseen by a psychiatrist, and integrated into a broader treatment plan tailored to your specific situation. If you have been researching ketamine options and want to understand whether in-person treatment at NeuPath is the right fit for you, we offer free consultations at all three locations. |
| Book a free consultation at NeuPath Mind Wellness today. |
